Risk factors and outcomes of post‐transplant erythrocytosis among adult kidney transplant recipients: a systematic review and meta‐analysis
Transplant International · 2021-11 · 34 (11) · 2071-2086
DOI: 10.1111/tri.14016 ↗At a glance
Metaanalyse in Transplant International, published online on 2021-09-23. Written by Poemlarp Mekraksakit and 7 co-authors. Institution: Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA. Major MEDLINE topics: Kidney Transplantation, Polycythemia, Transplants. Cited 10 times so far (Crossref); 77 references.
Abstract (original language)
Post-transplant erythrocytosis (PTE) can occur in up to 10-16% after kidney transplant (KT). However, the post-transplant outcomes of recipients with PTE in the literature were conflicting. We performed systematic review and meta-analysis of published studies to evaluate risk factors of PTE as well as outcomes of recipients who developed PTE compared with controls. A literature search was conducted evaluating all literature from existence through February 2, 2021, using MEDLINE and EMBASE. Data from each study were combined using the random-effects model. (PROSPERO: CRD42021230377). Thirty-nine studies from July 1982 to January 2021 were included (7,099 KT recipients). The following factors were associated with PTE development: male gender (pooled RR = 1.62 [1.38, 1.91], I2 = 39%), deceased-donor KT (pooled RR = 1.18 [1.03, 1.35], I2 = 32%), history of smoking (pooled RR = 1.36 [1.11, 1.67], I2 = 13%), underlying polycystic kidney disease (PKD) (pooled RR=1.56 [1.21, 2.01], I2 =44%), and pretransplant dialysis (pooled RR=1.6 [1.02, 2.51], I2 =46%). However, PTE was not associated with outcomes of interest, including overall mortality, death-censored graft failure, and thromboembolism. Our meta-analysis demonstrates that male gender, deceased-donor KT, history of smoking, underlying PKD, and pretransplant dialysis were significantly associated with developing PTE. However, with proper management, PTE has no impact on prognosis of KT patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
- Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
- Internal Medicine Residency Program, University of Hawaii, Honolulu, HI, USA.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
- Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
ORCID profiles: Poemlarp Mekraksakit, Boonphiphop Boonpheng, Natnicha Leelaviwat, Anasua Deb, Jakrin Kewcharoen, Wisit Cheungpasitporn
Cite
APA
Mekraksakit, P., Boonpheng, B., Leelaviwat, N., Duangkham, S., Deb, A., Kewcharoen, J., Nugent, K., & Cheungpasitporn, W. (2021). Risk factors and outcomes of post‐transplant erythrocytosis among adult kidney transplant recipients: a systematic review and meta‐analysis. Transplant International, 34(11), 2071-2086. https://doi.org/10.1111/tri.14016
Vancouver
Mekraksakit P, Boonpheng B, Leelaviwat N, Duangkham S, Deb A, Kewcharoen J, et al. Risk factors and outcomes of post‐transplant erythrocytosis among adult kidney transplant recipients: a systematic review and meta‐analysis. Transplant International. 2021;34(11):2071-2086. doi:10.1111/tri.14016
BibTeX
@article{Mekraksakit2021,
author = {Mekraksakit, Poemlarp and Boonpheng, Boonphiphop and Leelaviwat, Natnicha and Duangkham, Samapon and Deb, Anasua and Kewcharoen, Jakrin and Nugent, Kenneth and Cheungpasitporn, Wisit},
title = {Risk factors and outcomes of post‐transplant erythrocytosis among adult kidney transplant recipients: a systematic review and meta‐analysis},
journal = {Transplant International},
year = {2021},
volume = {34},
number = {11},
pages = {2071--2086},
doi = {10.1111/tri.14016}
}
EUVIMED